The Deal Register
Database › Equity financing › Science&Humans Closes $10M Oversubscribed Series A as Hormone Health…

Equity financing

Science&Humans Closes $10M Oversubscribed Series A as Hormone Health Emerges as a Core Pillar of Daily…

Lane
Equity financing
Announced
19 Jan 2026
Province
Ontario
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Science&Humans , a Canadian healthcare technology company that pioneered hormone health as a clinical and consumer category, announced today the close of its oversubscribed $10M Series A , combining equity and debt financing.
Source

The terms are in the subscriber edition

This transaction carries the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe